Israeli Digital Health Startup Showcase II: Innovations in Non-Invasive Diagnostics, Medical Imaging, Infant Communication, and Contactless Patient Monitoring

1. Elfi_Tech: Leader in Non-Invasive Remote Diagnostics

Elfi Tech is dedicated to the non-invasive measurement of physiological parameters. Leveraging its Elfi mDLS® sensor, the company has developed a suite of groundbreaking solutions for personal health monitoring, patient monitoring, and remote diagnostics, encompassing wearable sensing technologies, health and wellness management for patients with cardiovascular diseases, and real-time blood flow imaging technology.

?Elfi_Tech boasts a robust patent portfolio, encompassing software, hardware, and applications of its technologies.?

In addition, Elfi_Tech’s series of technological innovations are also applied in the military, healthcare, clinical, and consumer markets.

In early 2015, Elfi_Tech participated in the Consumer Electronics Show (CES), showcasing its PPG wrist-worn device capable of accurately measuring heart rate and heart rate variability during physical activity. Elfi_Tech also demonstrated its mDLS remote sensing platform, which measures additional parameters such as blood flow velocity, blood coagulation, vascular health, and enables application assessment.

As a developer of disruptive technologies, Elfi_Tech has devoted substantial efforts to identifying suitable strategic partners, aiming to bring its concepts to market. Currently, Elfi_Tech collaborates with multiple healthcare and integrated circuit companies worldwide to integrate innovative technologies into products, spanning both professional-grade and consumer-grade applications. Elfi_Tech also participates in Samsung’s digital health initiatives, having developed a heart rate sensing module for the Samsung Simband wearable platform, which was showcased at the Samsung Developer Conference in 2014.

Elfi_Tech was founded in 2006, with Ilya Fine serving as the company’s CEO. He has over 25 years of experience in medical device R&D and holds more than 40 patents for non-invasive measurement technologies (including blood oxygen saturation, hemoglobin, glucose, and blood flow). He previously served as CTO at OrSense and Cybro Medical.

Figure Caption: In October 2013, Elfi_Tech won the grand prize in the Sensor Innovation Challenge

2. Zebra: Next-Generation Medical Imaging Research Platform
Through computer vision and in-depth software research, Zebra has developed solutions with superior computational power and large-scale datasets to assist healthcare professionals in making more accurate patient diagnoses. The medical imaging research platform developed by Zebra holds significant value for physicians, scientists, and researchers who rely on medical images.

Eyal Gura, Co-founder and CEO of Zebra

3. Nuvo: Providing New Ways to Communicate with Infants and Toddlers
Composed of a dedicated team of engineers, scientists, and early childhood educators, NUVO is committed to providing users with innovative ways to communicate with infants and toddlers. Through years of diligent effort, NUVO has achieved industry leadership in product interactivity and safety for children across all age groups. NUVO aims to leverage emerging technologies—including big data, mobile applications, and cloud-based analytics—to create a new generation of products for infants and toddlers, thereby delivering greater convenience to every family.

Nuvo CEO Oren Oz

4. EarlySense: A Virtual Medical Assistant



EarlySense has developed a dynamic patient monitoring solution that functions as a virtual medical assistant, enhancing safety for patients receiving comprehensive care. The non-contact device can be placed under mattresses or chairs, depending on whether the patient is lying down or sitting, enabling real-time remote tracking of their condition.

In addition to routine comprehensive monitoring, several other significant benefits of the device include: attempting to predict patient deterioration in advance through detection and analysis; preventing falls and pressure ulcers; and mitigating alarm fatigue, which can lead to delays in treating critical conditions.

In practice, we have made the following observation: What matters to physicians is whether everything is normal or if care is needed. Patients, on the other hand, find value in having their condition transmitted to physicians via real-time device monitoring, prompting nurses to enter the room for adjustments. Heaven knows what would happen without these devices.

EarlySense once demonstrated its devices in several hospitals, but doctors did not initially flock to adopt them due to concerns about the efficacy of non-contact sensors. However, subsequent testing revealed that the product was highly beneficial for patient care. While EarlySense devices can be deployed in hospitals, rehabilitation centers, and healthcare systems, the company believes its largest market lies in home care, as this technology significantly reduces the duration of hospital observation stays for patients.

EarlySense Recently Secures $10 Million Investment from Samsung, Which Is Primarily Interested in Its Sensor Technology for Use in Developing Its Own IoT Products

Avner Halperin, a seasoned high-tech executive, serves as CEO of EarlySense. He has led companies including Emmunet, Radcom (NASDAQ: RDCM), and Lenslet. Tim O’Malley is the company’s President, bringing over 25 years of direct experience in the medical technology sector. He has consistently driven commercial success by delivering tangible value to patients and physicians.

Note: This series of special topics is provided by ETOU, and the related translation was completed by Liu Tianyong, a special correspondent for VCBeat.